FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Concentrations of neutrophil gelatinase-associated lipocalin...
Equine veterinary journal2022; 55(3); 426-434; doi: 10.1111/evj.13603

Concentrations of neutrophil gelatinase-associated lipocalin are increased in serum and peritoneal fluid from horses with inflammatory abdominal disease and non-strangulating intestinal infarctions.

Abstract: Neutrophil gelatinase-associated lipocalin (NGAL) is produced in response to inflammation in horses, but it has not yet been investigated as a biomarker in horses with the abdominal disease. Objective: To investigate NGAL in serum and peritoneal fluid in horses with the abdominal disease. Methods: Retrospective clinical study. Methods: Data from medical records of 270 horses admitted with acute abdominal disease (simple obstructions [n = 43], strangulating obstructions [n = 104], inflammatory abdominal disease [n = 99], non-strangulating intestinal infarction [NSII, n = 24]) and 9 healthy control horses were reviewed, and serum and peritoneal fluid samples were retrieved from a biobank. NGAL was measured in serum and peritoneal fluid by ELISA. Differences in NGAL concentrations between groups were assessed. Results: Healthy horses had low serum and peritoneal fluid concentrations of NGAL (median = 21.0 and 9.5 μg/L, respectively). Neither serum nor peritoneal fluid NGAL concentrations (median serum, peritoneal fluid) differed between healthy horses and horses with simple (28.1 μg/L, 13.0 μg/L) and strangulating intestinal obstructions (34.7 μg/L, 38.4 μg/L). Horses with NSII (308.0 μg/L, 2163.0 μg/L) and inflammatory abdominal disease (171.1 μg/L, 314.1 μg/L) had higher serum and peritoneal fluid concentrations of NGAL than the other groups (p < 0.001). Peritoneal fluid NGAL concentrations in horses with NSII were higher than in horses with inflammatory abdominal disease (p = 0.03). Conclusions: Retrospective study design; small group of control horses. Conclusions: NGAL is a marker of inflammation in horses with the abdominal disease. The high peritoneal fluid concentration of NGAL in horses with NSII compared to all other groups may render NGAL useful for identifying this condition, which is otherwise difficult to differentiate from other types of peritonitis. Thereby, NGAL may potentially facilitate timely surgical intervention in this group of patients. The results of this study must be evaluated in larger, and preferably prospective, studies to obtain a more comprehensive evaluation of the diagnostic utility of NGAL. Unassigned: Lipocalina associada à gelatinase de neutrófilos (NGAL) é produzida em resposta à inflamação em equinos, mas ainda não foi investigada como biomarcador de equinos com doenças abdominais. Objective: Investigar a NGAL no soro e líquido peritoneal (LP) de equinos com doenças abdominais. Unassigned: Estudo retrospectivo. Methods: Informação de prontuários médicos de 270 equinos com doença abdominal (obstrução simples [n = 43], obstrução estrangulante [n = 104], doença abdominal inflamatória [n = 99], lesão de infarto não estrangulante [NSII, n = 24]) e nove equinos saudáveis como controle foram revisados, e o soro e LP foram obtidos de um biobank. NGAL foi mensurado no soro e LP através de ELISA. Diferenças na concentração de NGAL entre os grupos foi avaliada. Results: Cavalos saudáveis tiveram concentração de NGAL baixas no soro e no LP (mediana = 21.0 e 9.5 μg/L, respectivamente). A concentração de NGAL no soro e no LP não diferiram entre cavalos saudáveis e cavalos com obstrução simples (28.1,13.0) e obstrução estrangulante (34.7, 38.4). Cavalos com NSII (308.0, 2163.0) e doença abdominal inflamatória (171.1314.1) tiveram concentrações mais altas de NGAL no soro e LP quando comparados aos outros grupos (p < 0.001). A concentração de NGAL no LP em cavalos com NSII foi mais alta do que em cavalos com doença abdominal inflamatória (p = 0.03). PRINCIPAIS LIMITAÇÕES: Delineamento de estudo retrospectivo e pequeno grupo de equinos controle. CONCLUSÕES: NGAL é um marcador de inflamação em cavalos com doença abdominal. A concentração alta de NGAL no LP de cavalos com NSII comparado com os outros grupos indica que NGAL pode ser útil em identificar essa condição, o que é usualmente difícil de diferenciar de outros tipos de peritonite. Contudo, NGAL tem o potencial de facilitar a decisão rápida da necessidade de intervenção cirúrgica nesse grupo de pacientes. Os resultados deste estudo devem ser avaliados em uma população maior (e preferencialmente prospectiva) para obter uma melhor avaliação compreensiva da utilidade diagnóstica do NGAL.
© 2022 The Authors. Equine Veterinary Journal published by John Wiley & Sons Ltd on behalf of EVJ Ltd.
Get Full Text
Publication Date: 2022-06-19 PubMed ID: 35642326DOI: 10.1111/evj.13603Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the potential of Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker in horses with abdominal disease. The results suggest that increased levels of NGAL in serum and peritoneal fluid can signify inflammation, and might be especially useful for the detection of non-strangulating intestinal infarction.

Objectives and Methodology

  • The primary objective of the research was to investigate the role of NGAL, a protein produced in response to inflammation, as a potential biomarker in horses with abdominal disease.
  • The study used a retrospective clinical approach utilizing data from medical records of 270 horses admitted with varying types of acute abdominal disease – simple obstructions, strangulating obstructions, inflammatory abdominal disease, and non-strangulating intestinal infarctions (NSII), along with 9 healthy control horses.
  • They retrieved serum and peritoneal fluid NGAL samples from a biobank and measured NGAL concentrations using ELISA. The concentrations between different groups were then compared for significant differences.

Results

  • Healthy horses confirmed low NGAL levels in both serum and peritoneal fluid.
  • No significant difference in NGAL concentrations was found between healthy horses and those with simple and strangulating obstructions.
  • However, horses with NSII and inflammatory abdominal disease showed significantly raised NGAL concentrations in both serum and peritoneal fluid.
  • Most notably, the peritoneal fluid NGAL concentrations in horses with NSII were higher than in those with inflammatory abdominal disease.

Conclusions

  • The retrospective study concluded that NGAL could serve as an inflammation marker in horses with abdominal disease.
  • Particularly, the high peritoneal fluid NGAL in horses with NSII as compared to all other groups may prove useful in detecting this condition. Typically, peritonitis types are challenging to differentiate, and NGAL may help in deciding for a timely surgical intervention.
  • The researchers caution that the results need further evaluation through larger, preferably prospective, studies for a more comprehensive assessment of NGAL’s diagnostic utility.

Limitations

  • One significant limitation is the study’s retrospective design, which could overlook potential confounding factors affecting the results.
  • Additionally, the small group of control horses may limit the generalizability of the conclusions.

Cite This Article

APA
Winther MF, Haugaard SL, Pihl TH, Jacobsen S. (2022). Concentrations of neutrophil gelatinase-associated lipocalin are increased in serum and peritoneal fluid from horses with inflammatory abdominal disease and non-strangulating intestinal infarctions. Equine Vet J, 55(3), 426-434. https://doi.org/10.1111/evj.13603

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 55
Issue: 3
Pages: 426-434

Researcher Affiliations

Winther, Malou F
  • University of Copenhagen, Department of Veterinary Clinical Sciences, Copenhagen, Denmark.
Haugaard, Simon L
  • University of Copenhagen, Department of Veterinary Clinical Sciences, Copenhagen, Denmark.
Pihl, Tina H
  • University of Copenhagen, Department of Veterinary Clinical Sciences, Copenhagen, Denmark.
Jacobsen, Stine
  • University of Copenhagen, Department of Veterinary Clinical Sciences, Copenhagen, Denmark.

MeSH Terms

  • Animals
  • Horses
  • Lipocalin-2
  • Retrospective Studies
  • Colic / veterinary
  • Ascitic Fluid
  • Prospective Studies
  • Horse Diseases / surgery
  • Intestinal Obstruction / veterinary
  • Inflammation / veterinary
  • Biomarkers
  • Infarction / veterinary

References

This article includes 50 references
  1. Nielsen MK, Vidyashankar AN, Olsen SN, Monrad J, Thamsborg SM. Strongylus vulgaris associated with usage of selective therapy on Danish horse farms-is it reemerging?. Vet Parasitol 2012;189:260-6.
    doi: 10.1016/j.vetpar.2012.04.039google scholar: lookup
  2. Hedberg-Alm Y, Penell J, Riihimäki M, Osterman-Lind E, Nielsen MK, Tydén E. Parasite occurrence and parasite management in Swedish Horses presenting with gastrointestinal disease-a case-control study. Animals 2020;10:638.
  3. Duncan JL, Pirie HM. The pathogenesis of single experimental infection with strongylus vulgaris in foals. Res Vet Sci 1973;18:82-93.
  4. Nielsen MK, Jacobsen S, Olsen SN, Bousquet E, Pihl T. Nonstrangulating intestinal infarction associated with Strongylus vulgaris in referred Danish equine cases. Equine Vet J 2016;48:376-9.
  5. Pihl TH, Nielsen MK, Olsen SN, Leifsson PS, Jacobsen S. Nonstrangulating intestinal infarctions associated with Strongylus vulgaris: clinical presentation and treatment outcomes of 30 horses (2008-2016). Equine Vet J 2018;50:474-80.
  6. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268:10425-32.
  7. Jayaraman A, Roberts KA, Yoon J, Yarmush DM, Duan X, Lee K. Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1β: a proteomic analysis. Biotechnol Bioeng 2005;91:502-15.
  8. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997;45:17-23.
  9. Mishra J, Qing MA, Prada A, Mitsnefes M, Zahedi K, Yang J. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14:2534-43.
  10. Aigner F, Maier HT, Schwelberger HG, Wallnöfer EA, Amberger A, Obrist P. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant 2007;7:779-88.
  11. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231-8.
  12. Lee Y-J, Hu Y-Y, Lin Y-S, Chang C-T, Lin F-Y, Wong M-L. Correction: urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury. BMC Vet Res 2013;9:228.
  13. Steinbach S, Weis J, Schweighauser A, Francey T, Neiger R. Plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) in dogs with acute kidney injury or chronic kidney disease. J Vet Intern Med 2014;28:264-9.
  14. Mårtensson J, Bell M, Oldner A, Xu S, Venge P, Martling C-R. Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 2010;36:1333-40.
  15. Jacobsen S, Berg LC, Tvermose E, Laurberg MB, van Galen G. Validation of an ELISA for detection of neutrophil gelatinase-associated lipocalin (NGAL) in equine serum. Vet Clin Pathol 2018;47:603-7.
  16. van Galen G, Jacobsen S, Vinther AM, Breinholt Laurberg M, Tvermose E, Broe-Brøndum R. 11th Annual European College of Equine Internal Medicine Congress 9-10 November, 2018. J Vet Intern Med 2019;33:1549.
  17. Frydendal C, Nielsen KB, Berg LC, van Galen G, Adler DMT, Andreassen SM. Influence of clinical and experimental intra-articular inflammation on neutrophil gelatinase-associated lipocalin concentrations in horses. Vet Surg 2021;50:641-9.
  18. Oikonomou KA, Kapsoritakis AN, Theodoridou C, Karangelis D, Germenis A, Stefanidis I. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol 2012;47:519-30.
  19. Budzyńska A, Nowakowska-Duława E, Gawron-Kiszka M, Spiewak J, Lesinska M, Kukla M. Serum neutrophil gelatinase-associated lipocalin correlates with Mayo Clinic score in ulcerative colitis but fails to predict activity in Crohn's disease. J Crohns Colitis 2017;11:S172-2.
  20. Bolignano D, Della Torre A, Lacquaniti A, Costantino G, Fries W, Buemi M. Neutrophil gelatinase-associated lipocalin levels in patients with Crohn disease undergoing treatment with infliximab. J Invest Med 2010;58:569-71.
  21. Nielsen OH, Gionchetti P, Ainsworth M, Vainer B, Campieri M, Borregaard N. Rectal dialysate and fecal concentrations of neutrophil gelatinase- associated lipocalin, interleukin-8, and tumor necrosis factor-α in ulcerative colitis. Am J Gastroenterol 1999;94:2923-8.
  22. Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest 1995;55:577-88.
  23. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 1996;38:414-20.
  24. Pihl TH, Scheepers E, Sanz M, Goddard A, Page P, Toft N. Influence of disease process and duration on acute phase proteins in serum and peritoneal fluid of horses with colic. J Vet Intern Med 2015;29:651-8.
  25. Cook VL, Hassel DM. Evaluation of the colic in horses. Decision for referral. Vet Clin North Am Equine Pract 2014;30:383-98.
  26. Underwood C, Southwood LL, McKeown KP, Knight D. Complications and survival associated with surgical compared with medical management of horses with duodenitis-proximal jejunitis. Equine Vet J 2008;40:373-8.
  27. Dyson S. Review of 30 cases of peritonitis in the horse. Equine Vet J 1983;15:25-30.
  28. le Jeune S, Whitcomb MB. Ultrasound of the equine acute abdomen. Vet Clin North Am Equine Pract 2014;30:353-81.
  29. Jacobsen S, Kjelgaard-Hansen M, Hagbard Petersen H, Jensen AL. Evaluation of a commercially available human serum amyloid A (SAA) turbidometric immunoassay for determination of equine SAA concentrations. Vet J 2006;172:315-9.
  30. Kjelgaard-Hansen M, Jacobsen S. Assay validation and diagnostic applications of major acute-phase protein testing in companion animals. Clin Lab Med 2011;31:51-70.
  31. Kent J. Acute phase proteins: their use in veterinary diagnosis. Br Vet J 1992;148:279-82.
  32. Jacobsen S, Vinther AM, Kjelgaard-Hansen M, Nielsen LN. Validation of an equine serum amyloid A assay with an unusually broad working range. BMC Vet Res 2019;15:1-9.
  33. Pihl TH, Scheepers E, Sanz M, Goddard A, Page P, Cand NT. Acute-phase proteins as diagnostic markers in horses with colic. J Vet Emerg Crit Care (San Antonio) 2016;26:664-74.
  34. Eurell TE, Wilson DA, Baker GJ. The effect of exploratory laparotomy on the serum and peritoneal haptoglobin concentrations of the pony. Can J Vet Res 1993;57:42-4.
  35. Abella V, Scotece M, Conde J, Gómez R, Lois A, Pino J. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers 2015;20:565-71.
  36. Spanton JA, Mair TS, Sherlock CE, Fews D. Non-strangulating intestinal infarction in horses in the UK: a review of 15 cases. Equine Vet Educ 2020;32:603-10.
  37. Southwood LL, Russell G. The use of clinical findings in the identification of equine peritonitis cases that respond favorably to medical therapy: retrospective study. J Vet Emerg Crit Care 2007;17:382-90.
  38. Carlson M, Raab Y, Sevéus L, Xu S, Hällgren R, Venge P. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut 2002;50:501-6.
  39. Haase-Fielitz A, Haase M, Devarajan P. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann Clin Biochem 2014;51:335-51.
  40. Zhang Y, Fan Y, Mei Z. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification. Cancer Epidemiol 2012;36:294-9.
  41. Cho HB, Kim JH. Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer. J Histochem Cytochem 2009;57:513-21.
  42. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006;26:136-42.
  43. Law IKM, Xu A, Lam KSL, Berger T, Mak TW, Vanhoutte PM. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 2010;59:72-882.
  44. Moreno-Navarrete JM, Manco M, Ibá̃ez J, García-Fuentes E, Ortega F, Gorostiaga E. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int J Obes 2010;34:240-9.
  45. Dai X, Zeng Z, Fu C, Zhang S, Cai Y, Chen Z. Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury. Crit Care 2015;19:1-10.
  46. Seanor JW, Byars TD, Boutcher JK. Renal disease associated with colic in horses. Mod Vet Pract 1984;65:A26-9.
  47. Geor RJ. Acute renal failure in horses. Vet Clin North Am Equine Pract 2007;23:577-91.
  48. DeNotta SAL, Divers TJ. Clinical pathology in the adult sick horse: the gastrointestinal system and liver. Vet Clin North Am Equine Pract 2020;36:105-20.
  49. Pedersen KR, Ravn HB, Hjortdal VE, Nørregaard R, Povlsen JV. Neutrophil gelatinase-associated Lipocalin (NGAL): validation of commercially available ELISA. Scand J Clin Lab Invest 2010;70:374-82.
  50. Schuh MP, Nehus E, Ma Q, Haffner C, Bennett M, Krawczeski CD. Long-term stability of urinary biomarkers of acute kidney injury in children. Am J Kidney Dis 2016;67:56-61.

Citations

This article has been cited 4 times.
  1. Laurberg M, Saegerman C, Jacobsen S, Berg LC, Laursen SH, Hoeberg E, Sånge EA, van Galen G. Use of admission serum neutrophil gelatinase-associated lipocalin (NGAL) concentrations as a marker of sepsis and outcome in neonatal foals. PLoS One 2023;18(5):e0285819.
    doi: 10.1371/journal.pone.0285819pubmed: 37200285google scholar: lookup
  2. Jacobsen S, Mortensen CD, Høj EA, Vinther AM, Berg LC, Adler DMT, Verwilghen D, van Galen G. Neutrophil Gelatinase-Associated Lipocalin in Synovial Fluid from Horses with and without Septic Arthritis. Animals (Basel) 2022 Dec 21;13(1).
    doi: 10.3390/ani13010029pubmed: 36611638google scholar: lookup
  3. Galen GV, Olsen E, Siwinska N. Biomarkers of Kidney Disease in Horses: A Review of the Current Literature. Animals (Basel) 2022 Oct 5;12(19).
    doi: 10.3390/ani12192678pubmed: 36230418google scholar: lookup
  4. Eskandari G, Ahmadi Sheikhsarmast S, Ghasemi S, Mohri M. Establishing Reference Values for Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Turkmen Horses: Effects of Gender, Age, Pregnancy and Physical Activity. Vet Med Sci 2026 Jan;12(1):e70755.
    doi: 10.1002/vms3.70755pubmed: 41456952google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.